With the rise of telehealth utilization in response to COVID-19 there has also been an increased interest in how telehealth vendors and practitioners protect and use health data.  This has led to policymakers and regulators proposing or implementing policies to address the type of information collected, how it’s used, and what needs to be disclosed to the patients. While part of this discussion is related to the concerns over privacy and protection of reproductive health information, several recent actions taken by federal agencies have focused on the use of collected data for marketing purposes.